Digital health reimbursement: A scoping review of global lessons and policy implications [PDF]
Digital HealthBackground Digital health technologies have expanded access to healthcare services by improving disease management and reducing unnecessary hospitalizations.
Reza Rabiei, Sohrab Almasi
doaj +2 more sources
Pathing the way from regulatory approval to market access for gene therapy products (GTPs): An integrative review in the US, EU5, Japan and China [PDF]
Regenerative TherapyBackground: This study aimed to summarize the current practices and mechanisms of market access, pricing and reimbursements for gene therapy products (GTPs) in major jurisdictions, and to identify the key barriers and facilitators affecting the ...
Junnan Shi, Hao Hu, Carolina Oi Lam Ung
doaj +2 more sources
Access to Medicines in Bulgaria and North Macedonia: Legislative, Pricing, and Reimbursement Perspectives [PDF]
PharmacyNational legislative frameworks governing prescribing, pricing, reimbursement, and dispensing play a decisive role in shaping access to medicines. This study examines the financial availability of medicines in Bulgaria and North Macedonia through a ...
Anna Todorova +4 more
doaj +2 more sources
JMIR mHealth and uHealth, 2023 BackgroundThe adoption of digital health care within health systems is determined by various factors, including pricing and reimbursement. The reimbursement landscape for digital health in Europe remains underresearched.
Robin van Kessel +10 more
doaj +1 more source
Healthcare Reimbursement and Quality Improvement: Integration Using the Electronic Medical Record; Comment on “Fee-for-service Payment - an Evil Practice That Must Be Stamped Out?” [PDF]
International Journal of Health Policy and Management, 2015 Reimbursement for healthcare has utilized a variety of payment mechanisms with varying degrees of effectiveness. Whether these mechanisms are used singly or in combination, it is imperative that the resulting systems remunerate on the basis of the ...
John R. Britton
doaj +1 more source
Frontiers in Pharmacology, 2017 Objectives: To explore whether Heberprot-P (an epidermal growth factor) is a cost-effective option for the treatment of advanced diabetic foot ulcer as an add-on therapy to good wound care (GWC) in Slovakia from the perspective of health care payers ...
Tomas Tesar +8 more
doaj +1 more source
BMC Health Services Research, 2022 Objectives To (1) describe the (evidence-based) reimbursement process of hospital individual services, (2) evaluate the accordance between evidence-based recommendations and reimbursement decision of individual services and (3) elaborate potential ...
Gregor Goetz +3 more
doaj +1 more source
Reimbursement decision-making system in Poland systematically compared to other countries
Frontiers in Pharmacology, 2023 Introduction: Our objective was to analyze and compare systematically and structurally reimbursement systems in Poland and other countries.Methods: The systems were selected based on recommendations issued by the Polish Agency for Health Technology ...
Aneta Mela +5 more
doaj +1 more source
Economic evaluation in stratified medicine: methodological issues and challenges
Frontiers in Pharmacology, 2016 Background: Stratified Medicine (SM) is becoming a practical reality with the targeting of medicines by using a biomarker or genetic-based diagnostic to identify the eligible patient sub-population. Like any healthcare intervention, SM interventions have
Hans-Joerg eFugel +3 more
doaj +1 more source
Satisfied or Reimbursed: An Innovative Index-Based Mechanism for the Environmental Protection of a Tourist Region [PDF]
Sustainability, 2020 This article describes and discusses an innovative index-based environmental protection mechanism involving both tourists and local firms of a given region. The public administration offers tourists (non-polluting firms) the possibility of being reimbursed if the environmental quality in the region turns out to be below (above) a given threshold level.
openaire +4 more sources